A Phase I, Open-Label Trial to Investigate the Pharmacokinetic Interaction Between TMC125 and Two Antifungal Agents (Fluconazole and Voriconazole), All at Steady-State in Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 01 Jan 2013
At a glance
- Drugs Etravirine (Primary) ; Fluconazole; Voriconazole
- Indications Aspergillosis; Candidiasis; Fusariosis; HIV infections; Mycoses
- Focus Pharmacokinetics
- Sponsors Janssen R&D Ireland
- 14 Sep 2009 Results were presented at ICAAC, San Francisco, USA, Sept, 2009.
- 18 Apr 2009 Actual end date (Jan 2009 ) added as reported by ClinicalTrials.gov.
- 18 Apr 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.